北京科鋭(002350.SZ)擬1014萬元認購瑞華股份定向發行的195萬股
格隆匯8月23日丨北京科鋭(002350.SZ)公佈,公司擬使用自有資金1014萬元認購蘭考瑞華環保電力股份有限公司(以下簡稱“瑞華股份”)定向發行的股份195萬股,每股認購價格為人民幣5.2元。
瑞華股份本次擬發行股票不超過2,300萬股(含2,300萬股),募集資金金額不超過人民幣11,960萬元(含11,960萬元)。
公司本次參與瑞華股份定向發行股份是看好瑞華股份未來發展及盈利能力,本次投資作為公司的一項財務性投資,未來可能會給公司帶來可期的投資回報,為公司帶來新的利潤點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.